title: [Acute alveolitis due to mesalazine].
abstract: A 66-year-old male developed lymphocytic alveolitis with bronchiolitis after 3 month's treatment with mesalazin for ulcerative colitis. The patient's symptoms disappeared after halting mesalazin and increasing the steroid dose, the reduced diffusing capacity ameliorated and the thoracic X-ray normalized. The question whether this was a case of pulmonary involvement in inflammatory bowel disease or a drug side effect.
authors.affiliation: Schweizerische Arzneimittel-Nebenwirkungs-Zentrale, SANZ, Chur.
authors.forename: U
authors.initials: U
authors.lastname: Lagler
authors.forename: H K
authors.initials: HK
authors.lastname: Schulthess
authors.forename: M
authors.initials: M
authors.lastname: Kuhn
mesh_terms: D000368:Aged; D000542:Alveolitis, Extrinsic Allergic / Q000139:chemically induced* / Q000503:physiopathology; D000636:Aminosalicylic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D001988:Bronchiolitis / Q000139:chemically induced; D003093:Colitis, Ulcerative / Q000188:drug therapy; D006801:Humans; D008297:Male; D019804:Mesalamine; D011653:Pulmonary Diffusing Capacity / Q000187:drug effects
chemical_list: D000636:Aminosalicylic Acids; D019804:Mesalamine
vernacular_title: Akute Alveolitis unter Mesalazin.